CureVac

CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration
CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration
Biopharma Reporter
CureVac
logistics
vaccines
COVID-19
Flag link:
CureVac climbs on vaccine data despite tolerability questions
CureVac climbs on vaccine data despite tolerability questions
Fierce Biotech
CureVac
vaccines
clinical trials
Flag link:
CureVac posts an upbeat take on interim PhI Covid-19 vaccine results, with a pivotal study looming. But you'll have to wait on data
CureVac posts an upbeat take on interim PhI Covid-19 vaccine results, with a pivotal study looming. But you'll have to wait on data
Endpoints
CureVac
COVID-19
vaccines
clinical trials
Flag link:
CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate CVnCoV
CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate CVnCoV
Drugs.com
CureVac
animal studies
MRNA
COVID-19
vaccines
CVnCoV
Flag link:
You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0
You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0
Fierce Biotech
MRNA
Moderna Therapeutics
BioNTech
CureVac
Kernal Bio
cancer
COVID-19
Flag link:
BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund
BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund
Pharmaforum
Germany
vaccines
BioNTech
CureVac
COVID-19
Flag link:
CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses
CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses
Fierce Pharma
CureVac
Europe
vaccines
MRNA
COVID-19
Flag link:
Curevac rides the Covid wave
Curevac rides the Covid wave
EP Vantage
CureVac
IPOs
vaccines
MRNA
COVID-19
Flag link:
CureVac grabs $213M in US IPO, adding to year's record pace
CureVac grabs $213M in US IPO, adding to year's record pace
BioPharma Dive
CureVac
IPOs
vaccines
Flag link:
GSK hands CureVac $294M to form mRNA infectious disease pact
GSK hands CureVac $294M to form mRNA infectious disease pact
Fierce Biotech
GSK
CureVac
MRNA
COVID-19
vaccines
monoclonal antibodies
Flag link:
After CureVac nabs government backing, BioNTech sees $250M private investment
After CureVac nabs government backing, BioNTech sees $250M private investment
Fierce Biotech
vaccines
COVID-19
Germany
BioNTech
CureVac
Flag link:
CureVac gets OK to start testing mRNA COVID-19 vaccine in humans
CureVac gets OK to start testing mRNA COVID-19 vaccine in humans
Fierce Pharma
CureVac
COVID-19
vaccines
MRNA
clinical trials
Flag link:
Germany stakes its claim over Curevac
Germany stakes its claim over Curevac
EP Vantage
Germany
CureVac
vaccines
pandemic
COVID-19
Flag link:
Crisis, what crisis? Curevac denies everything
Crisis, what crisis? Curevac denies everything
EP Vantage
COVID-19
coronaviruses
CureVac
Germany
vaccines
Donald Trump
Flag link:
COVID-19 drugmaker switches CEOs for second time in 5 days
COVID-19 drugmaker switches CEOs for second time in 5 days
Bizjournals
CureVac
vaccines
COVID-19
Flag link:
Germany Tries to Stop U.S. Poaching German Firm Seeking Coronavirus Vaccine
Germany Tries to Stop U.S. Poaching German Firm Seeking Coronavirus Vaccine
Reuters
Germany
CureVac
vaccines
Donald Trump
coronaviruses
COVID-19
Flag link:
CureVac CEO replaced in midst of biotech's coronavirus push
CureVac CEO replaced in midst of biotech's coronavirus push
BioPharma Dive
CureVac
vaccines
COVID-19
Daniel Menichella
Pharma CEOs
Flag link:
CureVac and Yale Team Up for mRNA-Based Lung Therapies
CureVac and Yale Team Up for mRNA-Based Lung Therapies
BioSpace
CureVac
Yale
MRNA
lung disease
R&D
Flag link:
Moderna’s Not the Only One: A Look at the mRNA Market
Moderna’s Not the Only One: A Look at the mRNA Market
BioSpace
MRNA
Moderna Therapeutics
Pfizer
BioNTech
CureVac
Translate Bio
Flag link:
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact
Xconomy
Eli Lilly
MRNA
cancer vaccines
CureVac
Flag link:

Pages